Engineered collagen-binding serum albumin as a drug conjugate carrier for cancer therapy

Abstract Collagen-binding ability improves serum albumin as an anti-cancer drug carrier, resulting in enhanced therapeutic efficacy. Authors: Koichi Sasaki ⚬, Jun Ishihara ⚬, Ako Ishihara ⚬, Risako Miura ⚬, Aslan Mansurov ⚬, Kazuto Fukunaga ⚬, Jeffrey A. Hubbell ⚬ License: Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC). CC BY-NC 4.0 This is